Speech Introduce
The Current Status of Medical Artificial Intelligence Development in Taipei-Veterans General Hospital
Abstract Of Speech

The AI development in Taipei-Veterans General Hospital was primarily sponsored by the government research funding , our own institute and industry cooperation, which are initial propellers to produce articles, patents, technology transfer, and international activities, guidelines of federated learning and to cultivate our medical AI staffs. There is no doubt that the high technology industry is very important on the roadmap of the medical AI development in Taiwan. We could share our experience and huge amount of previous health data for analysis with to booster projects progression and create innovation. Our goal for a smart hospital aims to build the digital OR, AI medical record, and smart OPD and inward care on the roadmap of AI development. To cope with this, time, manpower, brain storming and investment are necessary. The future development of the medical AI needs more engagement of talented manpower, cross-field cooperation to gain more resources from government and industry support which is the key to cultivate the younger generation of medical AI experts. On the other hand, we need a nation-wide consortium to assist an efficient administrative processing to fasten the speed of any novel idea to project, project to patent, product to verification of AI based software as medical device (SaMD) and global market analysis. In this talk, I will give an overview of “The Current Status of Medical Artificial Intelligence Development in Taipei-Veterans General Hospital”.

Invited Speaker
Name : Shou-Yen Kao

Current Position :
Vice Superintendent
Director, Medical AI Center
Taipei-Veterans General Hospital
Professor- National Yang-Ming Chiao-Tung University

Affiliation : Taipei Veterans General Hospital

e-mail : sykao@vghtpe.gov.tw

Professor Shou-Yen Kao was the President of Asian Association of Oral & Maxillofacial Surgeon and Organizing Committee Chair of 13th Asian Congress of Oral & Maxillofacial Surgery 2018 in Taipei. He is a dentist and an oral surgeon with 35 years of practice experience. He started his research interest in oral cancer since 1993 when he studied in the Doctor of Medical Science program at Harvard School of Dental Medicine. He has published above 200 SCI articles in the fields of oral cancer research and clinical aspect. He was the team leader of “Excellent research project in oral cancer translation medicine” by governmental support. Dr Kao earned the MHA degree in 2002 and had been the department head of Stomatology in Taipei-Veterans General Hospital & Associate Dean in National Yang-Ming University School of Dentistry since 2008. Professor Kao was promoted as the Vice Superintendent of Taipei-VGH in 2016. Currently, Dr Kao is also the director of medical AI center, responsible for the medical AI development in Taipei-VGH. He is going to give an outlook of current status of medical AI development in Taipei-Veterans General Hospital.


1978 - 1984 DDS. Nation Yang-Ming University, College of Dentistry, Taipei, Taiwan

1993 - 1996 DrMSc. Harvard University, School of Dental Medicine, Boston, U.S.A.

2000 - 2002 MHA Chang-Gang University, School of Management, Taiwan

Work Experience

2003 - 2008 Chair, Division of Oral & Maxillofacial Surgery, Taipei-VGH

2008 - 2016 Head, Department of Stomatology (Dentistry), Taipei-VGH, Taiwan

2016 - Vice Superintendent, Taipei-VGH, Taiwan

2016 -2018 President, 13th Asian Association of Oral & Maxillofacial Surgeons

2018 - Congress President, 13th Asian Congress of Oral & Maxillofacial Surgery

2019 - Special Contribution Award, TAOMS

2020 - Gold Medal Award for Special Contribution by Taiwan Dental Association

2021- Director, AI medical development center, Taipei-VGH

2022- Specialist service award of Ministry of Health and Welfare

1987-2022 227 SCI publications.

Areas Of Expertise

Specialist of Oral and Maxillofacial Surgery

Ming-Fong Lu
Current Positions

Secretary General, Taipei Biotech Industry Association

Adjunct Associate Professor, Public Health School, National Taiwan University

Board Director, Taiwan Association for Medical Informatics

Founder & CEO, Integrated Medical System


Chief Medical Adviser, Xin-Yi Health Center (ENN Energy group, China)

Senior Consultant, Shin-Kong Venture Capital Corp.

Senior Consultant, MicroBio Corp.

Adjunct Associate Professor, Department of Biochemical Science & Technology, National Taiwan University

President & CEO, Targetgen Biotechnology Co. Ltd.

Strategical Consultant, Vita Genomics Inc., Taiwan

Vice President, Department of Business Development, Vita Genomics Inc., Taiwan

Vice President, Department of Business Development, ADImmune Co., Taiwan

Vice President, Department of R & D, China Chemical and Pharmaceutical Co., Taiwan

Executive Officer, Department of Medical Affairs, Glaxo Taiwan

Associate Professor, National Tsing-Hua University, Taiwan

Medical Instructor, Purdue University, USA